Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000937

Drug Information
NameRitodrine
SynonymsL000737; 4-[2-[[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; LS-187116; CID31729; CAS-23239-51-2; EINECS 247-879-9; Prestwick0_000349; Utopar; BRD-K51465424-003-03-6; KBio2_001898; AC1LEMBZ; Benzenemethanol, 4-hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)-, (R*,S*)-; D02359; Prestwick3_000349; Prestwick2_000349; RITODRINE HCL; NCGC00016773-01; Spectrum4_000438; Ritodrinium; AC1LEMBT; Spectrum_001418; Ritodrinium [INN-Latin]; CID688570; KBio2_007034; NCGC00162324-02; Ritodrina [INN-Spanish]; AC1L1PV2; Lopac0_001041; AC1L1M7Q; 4-Hydroxy-alpha-(1-((2-(4-hydroxyphenyl)ethyl)amino)ethyl)benzenemethanol (R*,S*)-; Spectrum3_001458; KBio3_002455; NCGC00015887-01; BPBio1_000459; KBio2_004466; KBioGR_000796; Ritodrine [USAN:BAN:INN]; 4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; BRD-A59174698-003-02-9; CHEMBL83063; 2-(4-Hydroxyphenethylamino)-1-(4-hydroxyphenyl)propanol; Yutopar; SPBio_001526; CHEMBL785; NCGC00179566-01; DB00867; 4-[2-[[(1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; AC1LEMBW; Spectrum2_001423; LS-30764; Ritodrina; erythro-p-Hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol; 4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; UNII-I0Q6O6740J; Ritodrine (USAN/INN); AC1Q59PF; BSPBio_000417; Yutopar S.R; NCGC00162324-01; Benzyl alcohol, p-hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)-, erythro-; SPBio_002338; CID688568; Prepar; Prestwick1_000349; DU-21220; Benzenemethanol, 4-hydroxy-.alpha.-[1-[[2-(4-hydroxyphenyl)ethyl]amino]ethyl]-, (R*,S*)-; AC1Q76UV; Lopac-R-0758; 4-[2-[[(1R,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol; Spectrum5_001225; BSPBio_002955; NCGC00015887-02; 26652-09-5; CID33572; p-Hydroxy-alpha-(1-((p-hydroxyphenethyl)amino)ethyl)benzyl alcohol; KBioSS_001898; CID688569; ritodrine; BRN 2388728; C07239
Trade NameYutopar
IndicationPremature labour
[ICD9: 644, 765   ICD10: O60.1, P07.3]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H21NO3/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(1
9)7-3-13/h2-9,12,17-21H,10-11H2,1H3
InChIKeyIOVGROKTTNBUGK-UHFFFAOYSA-N
Canonical SMILESCC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O    
Therapeutic ClassSympathomimetics
CAS NumberCAS 26652-09-5
FormulaC17H21NO3
PubChem Compound IDCID 31729.
PubChem Substance IDSID 4924962.
SuperDrug ATC IDG02CA01
SuperDrug CAS ID026652095;
TargetBeta adrenergic receptorAgonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071438 To Reference
Ref 2Acute tocolysis for uterine activity reduction in term labor: a review. Obstet Gynecol Surv. 2008 Jun;63(6):383-8; quiz 405. To Reference
Ref 3Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence. J Med Chem. 2001 Apr 26;44(9):1436-45. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543